Based on the discovery that drugs used to treat schizophrenia (antipsychotics, which reducedopamine) caused symptomssimilar to those in people with Parkinson's disease, a condition associated with lowDA levels Seeman
Therefore schizo might be the result of highlevels of DA (hyperdopaminergia) in subcorticalareas of the brain
IE: an excess of DAreceptors in pathways from the subcortex to Broca's area (responsible for speechproduction) may explainspecificsymptoms of schizophrenia such as poverty of speech and/or auditory hallucinations
Updated versions of the dopamine hypothesis
Davis et al proposed the addition of corticalhypodopaminergia i.e. abnormally low DA in the brain's cortex
Explain symptoms of schizophrenia
IE: lowDA in the prefrontalcortex (responsible for thinking) could explain cognitiveproblems i.e. negativesymptoms of schizophrenia
It has also been suggested that corticalhypodopaminergia leads to subcorticalhyperdopaminergia - so both high and low levels of dopamine in differentbrainregions are part of the updated version
Updated versions of the dopamine hypothesis:
As well as explaining the links between abnormalDAlevels and symptoms, current versions of the dopamine hypothesis try to explain the origins of abnormalDAfunction.
So it seems that both geneticvariations and earlyexperiences of stress, both psychological and physical, make some people more sensitive to corticalhypodopaminergia and hence subcorticalhyperdopaminergia (Howes et al)